Report: Reinventing product and portfolio value for the biopharmaceutical industryPartner Content Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing net...
pipeline, Roche leads the ranking, closely followed by U.S. company Pfizer. Among the global top 15 companies based on products in the pipeline, six were from the United States. In 2023,research and development spending in the pharmaceutical industrystood at over 260 billion U.S. dollars ...
Industry: Pharma & Healthcare Add to Cart Buy Now Global Hemophilia AAV Gene Therapy Market Research Report 2024 Hemophilia AAV gene therapy is an innovative treatment approach for hemophilia using adeno - associated virus (AAV) as a vector to transfer normal clotting factor genes into the bodies...
Alliance Pharma, a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry has closed the purchase ofDrug Development Solutions (DDS)from LGC. Ampersand Capital Partners and KKR & Co. Inc. Read... Solvias has acquired Utrecht, Netherlands-...
2013-2020 Revenue of China's Yunnan Baiyao Group 2022, by source Profits of the Nigerian pharmaceutical company Pharma Deko 2020 TopicsPharmaceutical industry in the U.S.Global pharmaceutical industryBiotech drugsTop pharmaceutical drugsPharmaceutical industry in the UK...
A pharma company refers to a company in the pharmaceutical industry that focuses on the manufacturing and development of drugs. It aims to produce high-quality drugs, make them accessible, and optimize production processes while reducing costs. These companies rely on advanced technologies, data acqui...
The Helix report: Is biopharma wired for future success? October 27, 2022- The biopharmaceutical industry has made remarkable achievements in the past decade, but is it equipped to leap still further ahead in the coming one? Company leaders’ answers to nine questions could prove decisive. ...
While almost all companies have or are developing strategies to deal with industry disruptions, less than 40 percent have scaled-up solutions; the majority are stalled in “pilot purgatory.” Pharma is not alone in experiencing the challenges of scaling up; other operations-intensive indu...
“This will be crucial in sustaining industry growth and bringing increasing numbers of therapies to patients. These findings show pharma companies now need to use platforms like CPhI much earlier to make sure they have the right suppliers and development partners to meet future demand and bring on...
WHAT’S IN THIS REPORT?This report details our annual forecast of US healthcare and pharma digital ad spending. It includes a comprehensive overview of total digital ad spending, as well as estimates by channel, device, and format. KEY STAT:The US healthcare and pharma industry will spend $...